Healthcare & Medical Devices Global On demand · 24-48h

Global Endovascular Aneurysm Repair Market Strategic Research Report

Global Endovascular Aneurysm Repair Market Strategic Researc…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Endovascular Aneurysm Repair Market
$3.3B2025
4.6%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Percutaneous EVAR Systems, Fenestrated EVAR Systems, Thoracic Aortic Stent-Grafts, Adjunct / Other Devices

By Application: Hospitals, Ambulatory Surgical Centers, Specialty Vascular Clinics

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Abbott Laboratories, Artivion Inc., B. Braun SE, Becton, Dickinson And Company, Bolton Medical Inc. (Palex Medical), Cardinal Health Inc. (Cordis), Cook Medical LLC, Edwards Lifesciences Corp., Endologix LLC, Getinge AB (Maquet), JOTEC GmbH (Terumo Aortic), Koninklijke Philips N.V., Medtronic plc, MicroPort Scientific Corp. (Endovastec), Terumo Corporation / Terumo Aortic, W. L. Gore & Associates, Inc.

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 150 pages
Market size 2025
$3.3B
Billion USD
Forecast CAGR
4.6%
2025-2032
Forecast 2032
$4.5B
Projected
Regions
5
Asia Pacific · Latin America · MEA · Europe · North America

Overview

Scope of the Report

Anyone assessing the global Endovascular Aneurysm Repair market will find its scope, segmentation, regional coverage and competitive analysis laid out in this report, together with the risks and sensitivities behind the outlook.

The scope is global, with separate views of product type, end application, five regions and 20 countries so that readers can focus on the parts of the market that matter to them.

Market Size Indicator

Published estimates for the global Endovascular Aneurysm Repair market cluster around US$ 3.3 billion in 2025. Growth over the forecast period is indicated at roughly 4.6% per year. These figures are indicative: they are triangulated from several independently published market estimates, which differ somewhat in scope and base year, and they are not a substitute for the full analysis. Final market size and growth figures are set out in the delivered report.

Market Segmentation

The Endovascular Aneurysm Repair market is segmented along the following dimensions, each assessed on its own growth outlook:

  • By Indication: Abdominal Aortic Aneurysm (AAA) and Thoracic Aortic Aneurysm (TAA)
  • By Site: Infrarenal and Pararenal
  • By Anatomy: Traditional and Complex
  • By Product: Percutaneous EVAR Systems, Fenestrated EVAR Systems, Thoracic Aortic Stent-Grafts and Adjunct / Other Devices
  • By End User: Hospitals, Ambulatory Surgical Centers and Specialty Vascular Clinics

Regional analysis covers Asia Pacific, North America, Europe, the Middle East and Africa and Latin America, with country-level forecasts.

Market Context

Suppliers in healthcare and medical devices generally face long qualification cycles, strict quality requirements and buyers who weigh safety against total cost of care. Over the forecast period, differences in technology, scale and customer relationships are likely to influence how share is distributed across the Endovascular Aneurysm Repair market.

Competitive Landscape

Company coverage spans 16 participants in Endovascular Aneurysm Repair, namely Abbott Laboratories, Artivion Inc., B. Braun SE, Becton, Dickinson And Company, Bolton Medical Inc. (Palex Medical), Cardinal Health Inc. (Cordis), Cook Medical LLC, Edwards Lifesciences Corp., Endologix LLC, Getinge AB (Maquet), JOTEC GmbH (Terumo Aortic), Koninklijke Philips N.V., Medtronic plc, MicroPort Scientific Corp. (Endovastec), Terumo Corporation / Terumo Aortic and W. L. Gore & Associates, Inc..

Profiles follow a consistent structure: overview, products and segments, financial performance, strategy, SWOT analysis and strategic implications.

What the Report Covers

Coverage is structured around:

  • Market definition and scope for Endovascular Aneurysm Repair, with the market size and growth forecast for 2026 to 2032
  • Segment outlook by type and by application
  • Regional outlook for five regions and country-level forecasts for 20 countries
  • The factors expected to push the Endovascular Aneurysm Repair market forward or hold it back, with an impact assessment of each
  • Company profiles and the competitive landscape, including competitive intensity and key player strategies
  • Structural analysis using the Porter's Five Forces, PESTLE and SWOT frameworks
  • Trends in technology and innovation, investment and M&A activity, and the long-term outlook for Endovascular Aneurysm Repair

The report is produced on demand to the scope described here and delivered in PDF within 24 to 48 hours of purchase.

Key Questions Answered

  • How large is the global Endovascular Aneurysm Repair market today, and how is it expected to grow between 2026 and 2032?
  • What is driving demand for Endovascular Aneurysm Repair, and what could slow growth?
  • Which product segments of Endovascular Aneurysm Repair - Percutaneous EVAR Systems, Fenestrated EVAR Systems and Thoracic Aortic Stent-Grafts - are positioned for the strongest growth?
  • How does the Endovascular Aneurysm Repair market differ by indication (Abdominal Aortic Aneurysm (AAA) and Thoracic Aortic Aneurysm (TAA))?
  • How does the Endovascular Aneurysm Repair market differ by site (Infrarenal and Pararenal)?
  • Which regions and countries are the largest and fastest-growing markets for Endovascular Aneurysm Repair?

Who Can Use This Report

  • Companies active in Endovascular Aneurysm Repair benchmarking their position and planning product, capacity and go-to-market strategy
  • Customers, distributors and channel partners such as Hospitals, Ambulatory Surgical Centers and Specialty Vascular Clinics evaluating demand and sourcing options
  • Investment professionals, advisers and strategy teams looking for a structured view of opportunity and risk
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Endovascular Aneurysm Repair Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 4.6%
Regional growth momentum
Market share by segment
Key metrics
Base value
$3.3B
2025
Forecast
$4.5B
2032
CAGR
4.6%
2025–2032
Regions
5
global
Key companies
Abbott LaboratoriesArtivion Inc.B. Braun SEBectonDickinson And CompanyBolton Medical Inc. (Palex Medical)Cardinal Health Inc. (Cordis)Cook Medical LLC
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Percutaneous EVAR SystemsFenestrated EVAR SystemsThoracic Aortic Stent-GraftsAdjunct / Other Devices
By Application
HospitalsAmbulatory Surgical CentersSpecialty Vascular Clinics

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Segment Outlook by Indication
  • 2.1.4 Segment Outlook by Site
  • 2.1.5 Segment Outlook by Anatomy
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Indication
  • 3.1 Market Segmentation by Indication
  • 3.1.1 Market by Indication Overview
  • 3.1.2 Abdominal Aortic Aneurysm (AAA)
  • 3.1.3 Thoracic Aortic Aneurysm (TAA)
04Market Segmentation by Site
  • 4.1 Market Segmentation by Site
  • 4.1.1 Market by Site Overview
  • 4.1.2 Infrarenal
  • 4.1.3 Pararenal
05Market Segmentation by Anatomy
  • 5.1 Market Segmentation by Anatomy
  • 5.1.1 Market by Anatomy Overview
  • 5.1.2 Traditional
  • 5.1.3 Complex
06Market Segmentation by Product
  • 6.1 Market Segmentation by Product
  • 6.1.1 Market by Product Overview
  • 6.1.2 Percutaneous EVAR Systems
  • 6.1.3 Fenestrated EVAR Systems
  • 6.1.4 Thoracic Aortic Stent-Grafts
  • 6.1.5 Adjunct / Other Devices
07Market Segmentation by End User
  • 7.1 Market Segmentation by End User
  • 7.1.1 Market by End User Overview
  • 7.1.2 Hospitals
  • 7.1.3 Ambulatory Surgical Centers
  • 7.1.4 Specialty Vascular Clinics
08Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
09Country-Level Market Forecast
  • 9.1 Asia Pacific
  • 9.1.1 China
  • 9.1.2 Japan
  • 9.1.3 India
  • 9.1.4 Australia
  • 9.1.5 South Korea
  • 9.1.6 Rest of Asia Pacific
  • 9.2 North America
  • 9.2.1 United States
  • 9.2.2 Canada
  • 9.2.3 Mexico
  • 9.2.4 Rest of North America
  • 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 United Kingdom
  • 9.3.3 France
  • 9.3.4 Italy
  • 9.3.5 Spain
  • 9.3.6 Rest of Europe
  • 9.4 Middle East & Africa
  • 9.4.1 GCC
  • 9.4.2 South Africa
  • 9.4.3 Rest of Middle East & Africa
  • 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Argentina
  • 9.5.3 Rest of Latin America
10Growth Drivers & Inhibitors
  • 10.1 Growth Drivers & Inhibitors
  • 10.1.1 Section Overview
  • 10.1.2 Growth Drivers
  • 10.1.3 Growth Inhibitors
  • 10.1.4 Driver and Inhibitor Impact Assessment
  • 10.1.5 Analyst Perspective
11Key Company Profiles
  • 11.1 Abbott Laboratories
  • 11.1.1 Company Overview
  • 11.1.2 Key Products & Segments
  • 11.1.3 Financial Performance (2023–2025)
  • 11.1.4 Business Strategy
  • 11.1.5 SWOT Analysis
  • 11.1.6 Strategic Implications (2026–2032)
  • 11.2 Artivion Inc.
  • 11.2.1 Company Overview
  • 11.2.2 Key Products & Segments
  • 11.2.3 Financial Performance (2023–2025)
  • 11.2.4 Business Strategy
  • 11.2.5 SWOT Analysis
  • 11.2.6 Strategic Implications (2026–2032)
  • 11.3 B. Braun SE
  • 11.3.1 Company Overview
  • 11.3.2 Key Products & Segments
  • 11.3.3 Financial Performance (2023–2025)
  • 11.3.4 Business Strategy
  • 11.3.5 SWOT Analysis
  • 11.3.6 Strategic Implications (2026–2032)
  • 11.4 Becton, Dickinson And Company
  • 11.4.1 Company Overview
  • 11.4.2 Key Products & Segments
  • 11.4.3 Financial Performance (2023–2025)
  • 11.4.4 Business Strategy
  • 11.4.5 SWOT Analysis
  • 11.4.6 Strategic Implications (2026–2032)
  • 11.5 Bolton Medical Inc. (Palex Medical)
  • 11.5.1 Company Overview
  • 11.5.2 Key Products & Segments
  • 11.5.3 Financial Performance (2023–2025)
  • 11.5.4 Business Strategy
  • 11.5.5 SWOT Analysis
  • 11.5.6 Strategic Implications (2026–2032)
  • 11.6 Cardinal Health Inc. (Cordis)
  • 11.6.1 Company Overview
  • 11.6.2 Key Products & Segments
  • 11.6.3 Financial Performance (2023–2025)
  • 11.6.4 Business Strategy
  • 11.6.5 SWOT Analysis
  • 11.6.6 Strategic Implications (2026–2032)
  • 11.7 Cook Medical LLC
  • 11.7.1 Company Overview
  • 11.7.2 Key Products & Segments
  • 11.7.3 Financial Performance (2023–2025)
  • 11.7.4 Business Strategy
  • 11.7.5 SWOT Analysis
  • 11.7.6 Strategic Implications (2026–2032)
  • 11.8 Edwards Lifesciences Corp.
  • 11.8.1 Company Overview
  • 11.8.2 Key Products & Segments
  • 11.8.3 Financial Performance (2023–2025)
  • 11.8.4 Business Strategy
  • 11.8.5 SWOT Analysis
  • 11.8.6 Strategic Implications (2026–2032)
  • 11.9 Endologix LLC
  • 11.9.1 Company Overview
  • 11.9.2 Key Products & Segments
  • 11.9.3 Financial Performance (2023–2025)
  • 11.9.4 Business Strategy
  • 11.9.5 SWOT Analysis
  • 11.9.6 Strategic Implications (2026–2032)
  • 11.10 Getinge AB (Maquet)
  • 11.10.1 Company Overview
  • 11.10.2 Key Products & Segments
  • 11.10.3 Financial Performance (2023–2025)
  • 11.10.4 Business Strategy
  • 11.10.5 SWOT Analysis
  • 11.10.6 Strategic Implications (2026–2032)
  • 11.11 JOTEC GmbH (Terumo Aortic)
  • 11.11.1 Company Overview
  • 11.11.2 Key Products & Segments
  • 11.11.3 Financial Performance (2023–2025)
  • 11.11.4 Business Strategy
  • 11.11.5 SWOT Analysis
  • 11.11.6 Strategic Implications (2026–2032)
  • 11.12 Koninklijke Philips N.V.
  • 11.12.1 Company Overview
  • 11.12.2 Key Products & Segments
  • 11.12.3 Financial Performance (2023–2025)
  • 11.12.4 Business Strategy
  • 11.12.5 SWOT Analysis
  • 11.12.6 Strategic Implications (2026–2032)
  • 11.13 Medtronic plc
  • 11.13.1 Company Overview
  • 11.13.2 Key Products & Segments
  • 11.13.3 Financial Performance (2023–2025)
  • 11.13.4 Business Strategy
  • 11.13.5 SWOT Analysis
  • 11.13.6 Strategic Implications (2026–2032)
  • 11.14 MicroPort Scientific Corp. (Endovastec)
  • 11.14.1 Company Overview
  • 11.14.2 Key Products & Segments
  • 11.14.3 Financial Performance (2023–2025)
  • 11.14.4 Business Strategy
  • 11.14.5 SWOT Analysis
  • 11.14.6 Strategic Implications (2026–2032)
  • 11.15 Terumo Corporation / Terumo Aortic
  • 11.15.1 Company Overview
  • 11.15.2 Key Products & Segments
  • 11.15.3 Financial Performance (2023–2025)
  • 11.15.4 Business Strategy
  • 11.15.5 SWOT Analysis
  • 11.15.6 Strategic Implications (2026–2032)
  • 11.16 W. L. Gore & Associates, Inc.
  • 11.16.1 Company Overview
  • 11.16.2 Key Products & Segments
  • 11.16.3 Financial Performance (2023–2025)
  • 11.16.4 Business Strategy
  • 11.16.5 SWOT Analysis
  • 11.16.6 Strategic Implications (2026–2032)
12Competitive Landscape
  • 12.1 Competitive Landscape Overview
  • 12.2 Competitive Intensity Assessment
  • 12.3 Key Player Strategies & Positioning
  • 12.4 Competitive Dynamics & Strategic Outlook
  • 12.4.1 Emerging Competitive Threats
  • 12.4.2 Consolidation vs. Fragmentation Outlook
  • 12.4.3 Competitive Response Matrix
  • 12.4.4 Strategic Recommendations, 2026–2032
13Porter's Five Forces Analysis
  • 13.1 Threat of New Entrants
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Threat of Substitutes
  • 13.5 Competitive Rivalry
14PESTLE Analysis
  • 14.1 Political
  • 14.2 Economic
  • 14.3 Social and Demographic
  • 14.4 Technological
  • 14.5 Legal and Regulatory
  • 14.6 Environmental
  • 14.7 Strategic Implications of the PESTLE Assessment
15SWOT Analysis
16Future Trends & Outlook
  • 16.1 Future Trends & Outlook
  • 16.1.1 Trend Summary and Commercial Maturity Assessment
  • 16.1.2 Technology and Innovation Trends
  • 16.1.3 Long-Term Market Outlook
  • 16.1.4 Investment & M&A Activity Outlook
  • 16.1.5 Overall Outlook Assessment

Frequently asked questions

Which regions and countries are covered for Endovascular Aneurysm Repair?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
How is the Endovascular Aneurysm Repair market segmented?
The market is segmented by Indication (Abdominal Aortic Aneurysm (AAA) and Thoracic Aortic Aneurysm (TAA)), Site (Infrarenal and Pararenal), Anatomy (Traditional and Complex), Product (Percutaneous EVAR Systems, Fenestrated EVAR Systems, Thoracic Aortic Stent-Grafts and Adjunct / Other Devices) and End User (Hospitals, Ambulatory Surgical Centers and Specialty Vascular Clinics), with forecasts for each segment.
Who are the key players in the Endovascular Aneurysm Repair market?
Key players profiled include Abbott Laboratories, Artivion, B. Braun SE, Becton, Dickinson And Company, Bolton Medical Inc. (Palex Medical), Cardinal Health Inc. (Cordis), Cook Medical, Edwards Lifesciences, Endologix, Getinge AB (Maquet) and 6 more, among 16 companies covered in total.
Who should buy the Endovascular Aneurysm Repair market report?
The report is intended for manufacturers and solution providers, distributors and end users, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Endovascular Aneurysm Repair market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

All data sources are cited within the report. View our full research methodology →
PURCHASE THIS REPORT
from $3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.